Bioloxía de membranas e mecanismos de transducción de sinais en farmacoloxía aplicada.
BioFarma
University of Liverpool
Liverpool, Reino UnidoPublicacións en colaboración con investigadores/as de University of Liverpool (3)
2020
-
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 106, Núm. 4, pp. 733-742
2014
-
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 829-840
2006
-
Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara
Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1764, Núm. 5, pp. 863-871